Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract Burkitt Lymphoma (BL) is common in sub-Saharan Africa, but its diagnosis is often delayed. Here, we comprehensively evaluate blood-based liquid biopsies from 377 children and young adults with clinically suspected lymphoma for diagnostic accuracy, yield and turnaround time (TAT). Following extensive pathology capacity building at participating study pathology sites to streamline and quality-ensure the histopathology assessment, diagnoses were reached from best local pathology consisting of tissue morphology, a previously validated limited immunohistochemistry (IHC) panel and review by at least two histopathologists, together called the “gold standard”. Next, we used a combination of clinical characteristics and circulating tumour DNA attributes ( MYC mutations, MYC-IG translocations, and EBV fragmentomics) to train five different diagnostic models based on penalised logistic regression and 10-fold cross-validation on 212 children and young adults with clinically suspected lymphoma. External real-world validation was conducted on the best-performing model on a prospective cohort of 56 children and young adults with clinically suspected lymphoma. Diagnostic accuracy, yield and TAT for the liquid biopsy test were compared head-to-head against the gold-standard in 58 children and young adults with clinically suspected lymphoma. All five models showed good discrimination for BL (AUC ≥ 0.8). The comprehensive model had the best overall performance with AUC of 0.94 (95% CI: 0.895–0.974; p = 4.86×10⁻⁴), sensitivity of 0.83, and specificity of 0.95 confirmed by external validation (AUC of 0.98 (95% CI: 0.942–1)). Liquid biopsy was the only diagnostic result available in the multi-disciplinary team meeting in 42% (26/61) of participants and reduced the median diagnostic TAT from 46.8 days to 6.5 days (p = 4.42e-10) compared to gold standard. This study demonstrates that our liquid biopsy model enables fast, highly accurate molecular diagnosis of EBV-positive BL. Its future integration into the diagnostic pathway may increase diagnostic accuracy and minimise treatment delays in resource-limited settings.
Full text 23,593 characters · extracted from preprint-html · click to expand
Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma Clara Chamba, Heavenlight Christopher, Emmanuel Josephat, Julius Seruyange, and 33 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6820773/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 19 Mar, 2026 Read the published version in Nature Medicine → Version 1 posted You are reading this latest preprint version Abstract Burkitt Lymphoma (BL) is common in sub-Saharan Africa, but its diagnosis is often delayed. Here, we comprehensively evaluate blood-based liquid biopsies from 377 children and young adults with clinically suspected lymphoma for diagnostic accuracy, yield and turnaround time (TAT). Following extensive pathology capacity building at participating study pathology sites to streamline and quality-ensure the histopathology assessment, diagnoses were reached from best local pathology consisting of tissue morphology, a previously validated limited immunohistochemistry (IHC) panel and review by at least two histopathologists, together called the “gold standard”. Next, we used a combination of clinical characteristics and circulating tumour DNA attributes ( MYC mutations, MYC-IG translocations, and EBV fragmentomics) to train five different diagnostic models based on penalised logistic regression and 10-fold cross-validation on 212 children and young adults with clinically suspected lymphoma. External real-world validation was conducted on the best-performing model on a prospective cohort of 56 children and young adults with clinically suspected lymphoma. Diagnostic accuracy, yield and TAT for the liquid biopsy test were compared head-to-head against the gold-standard in 58 children and young adults with clinically suspected lymphoma. All five models showed good discrimination for BL (AUC ≥ 0.8). The comprehensive model had the best overall performance with AUC of 0.94 (95% CI: 0.895–0.974; p = 4.86×10⁻⁴), sensitivity of 0.83, and specificity of 0.95 confirmed by external validation (AUC of 0.98 (95% CI: 0.942–1)). Liquid biopsy was the only diagnostic result available in the multi-disciplinary team meeting in 42% (26/61) of participants and reduced the median diagnostic TAT from 46.8 days to 6.5 days (p = 4.42e-10) compared to gold standard. This study demonstrates that our liquid biopsy model enables fast, highly accurate molecular diagnosis of EBV-positive BL. Its future integration into the diagnostic pathway may increase diagnostic accuracy and minimise treatment delays in resource-limited settings. Health sciences/Diseases/Haematological diseases/Haematological cancer/Lymphoma/Non-hodgkin lymphoma/B-cell lymphoma Health sciences/Diseases/Cancer/Cancer genomics Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryData.docx Supplementary Data Cite Share Download PDF Status: Published Journal Publication published 19 Mar, 2026 Read the published version in Nature Medicine → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6820773","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":469934082,"identity":"350caf52-e4ac-4c37-a588-2f537a5941ce","order_by":0,"name":"Clara Chamba","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA6klEQVRIiWNgGAWjYDACdjB5gIFBgoHxAZDFw0dQCzNCC7MBSAsbKVrYJEBMglr4m5mfffhRc0ded3bzs8qvOXYybAzMDx/dwKNF4jCb8cyeY88Mt905ZnZbdlsy0GFsxsY5eLQYMDMYM/A2HGbcdiPB7LbkNmagFh42afxa2D8z/m04bL/tRvq3Yslt9cRo4TFmBtqSuO1Gjhnjx22HCWuROMxTzCxz7HDytjtniqUZtx3nYWMm4Bf+9vbNjG9qDttuu92+8ePPbdX2/OzNDx/j04ICmHnAJLHKQYDxBymqR8EoGAWjYMQAAMHCRwul87hJAAAAAElFTkSuQmCC","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":true,"prefix":"","firstName":"Clara","middleName":"","lastName":"Chamba","suffix":""},{"id":469934083,"identity":"1f12027a-b7f1-4ed3-b45f-b11358917621","order_by":1,"name":"Heavenlight Christopher","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Heavenlight","middleName":"","lastName":"Christopher","suffix":""},{"id":469934084,"identity":"d19589e8-c50f-4bc1-a477-2aa8e3cf5d7e","order_by":2,"name":"Emmanuel Josephat","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Emmanuel","middleName":"","lastName":"Josephat","suffix":""},{"id":469934085,"identity":"b1ae9c56-b558-4238-9a4d-ba7f634a0689","order_by":3,"name":"Julius Seruyange","email":"","orcid":"","institution":"Central Public Health Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Julius","middleName":"","lastName":"Seruyange","suffix":""},{"id":469934086,"identity":"2a8a697b-1af0-4363-b519-90dc5d97c651","order_by":4,"name":"Alisen Ayitewala","email":"","orcid":"","institution":"Africa Centre for Disease Control and Prevention","correspondingAuthor":false,"prefix":"","firstName":"Alisen","middleName":"","lastName":"Ayitewala","suffix":""},{"id":469934087,"identity":"38a8d877-186d-4d12-932f-3ebdae8d729b","order_by":5,"name":"Kieran Howard","email":"","orcid":"https://orcid.org/0000-0003-3335-4940","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Kieran","middleName":"","lastName":"Howard","suffix":""},{"id":469934088,"identity":"120faa51-97d1-4f6b-a3e3-ecf4dfe31581","order_by":6,"name":"Helene Dreau","email":"","orcid":"","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Helene","middleName":"","lastName":"Dreau","suffix":""},{"id":469934089,"identity":"6600c10a-4e4c-40c9-b94d-678721c558d4","order_by":7,"name":"Adam Burns","email":"","orcid":"","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Adam","middleName":"","lastName":"Burns","suffix":""},{"id":469934090,"identity":"5c1eb7f9-36ab-4dfb-b23b-b60fb8e9def1","order_by":8,"name":"Ismail Legason","email":"","orcid":"","institution":"St. Mary's Hospital, Lacor","correspondingAuthor":false,"prefix":"","firstName":"Ismail","middleName":"","lastName":"Legason","suffix":""},{"id":469934091,"identity":"0173ea64-926f-4d13-bad5-34177edd3e30","order_by":9,"name":"Isaac Otim","email":"","orcid":"","institution":"African Field Epidemiology Network","correspondingAuthor":false,"prefix":"","firstName":"Isaac","middleName":"","lastName":"Otim","suffix":""},{"id":469934092,"identity":"e51a504f-3216-4abf-bb0f-a5ad621aad74","order_by":10,"name":"Priscus Mapendo","email":"","orcid":"","institution":"Kilimanjaro Christian Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Priscus","middleName":"","lastName":"Mapendo","suffix":""},{"id":469934093,"identity":"b1a3e97b-ce4a-4f22-9556-5abba97a9969","order_by":11,"name":"Leah Mnango","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Leah","middleName":"","lastName":"Mnango","suffix":""},{"id":469934094,"identity":"3c94260f-cea8-4d03-99a8-5f145b624367","order_by":12,"name":"Advera Ngaiza","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Advera","middleName":"","lastName":"Ngaiza","suffix":""},{"id":469934095,"identity":"c10c7c68-39f4-488a-8d09-671e16b08520","order_by":13,"name":"Alex Mremi","email":"","orcid":"https://orcid.org/0000-0001-7226-0168","institution":"Kilimanjaro Christian Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Alex","middleName":"","lastName":"Mremi","suffix":""},{"id":469934096,"identity":"4935b34b-6736-4194-a9e0-ef4bccd9bfe7","order_by":14,"name":"Edrick Elias","email":"","orcid":"","institution":"Bugando Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Edrick","middleName":"","lastName":"Elias","suffix":""},{"id":469934097,"identity":"201f0051-0daf-4ed7-9ad0-f11178a18eaf","order_by":15,"name":"Carol Achola","email":"","orcid":"","institution":"Central Public Health Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Carol","middleName":"","lastName":"Achola","suffix":""},{"id":469934098,"identity":"eb2f96e4-548a-4778-b789-44e61a760699","order_by":16,"name":"William Mawalla","email":"","orcid":"https://orcid.org/0000-0002-0016-7551","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"William","middleName":"","lastName":"Mawalla","suffix":""},{"id":469934099,"identity":"cea76d2a-b484-45a4-8854-e24876378c0a","order_by":17,"name":"Rehema Shungu","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Rehema","middleName":"","lastName":"Shungu","suffix":""},{"id":469934100,"identity":"52b6289a-b84c-4d53-aaea-1fb8623ff473","order_by":18,"name":"Eli Mkwizu","email":"","orcid":"","institution":"Kilimanjaro Christian Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Eli","middleName":"","lastName":"Mkwizu","suffix":""},{"id":469934101,"identity":"8b869413-cfb5-4e52-be7e-562847a45298","order_by":19,"name":"Lulu Chirande","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Lulu","middleName":"","lastName":"Chirande","suffix":""},{"id":469934102,"identity":"f2d0293a-1666-4e93-88f1-e7350d65909c","order_by":20,"name":"Hadija Mwamtemi","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Hadija","middleName":"","lastName":"Mwamtemi","suffix":""},{"id":469934103,"identity":"09ecfda5-9c6b-408d-9c14-b52247c0b859","order_by":21,"name":"Salama Mahawi","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Salama","middleName":"","lastName":"Mahawi","suffix":""},{"id":469934104,"identity":"846c969a-371e-4855-9667-e3f1846dc33d","order_by":22,"name":"Godlove Sandi","email":"","orcid":"https://orcid.org/0000-0001-9068-0991","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Godlove","middleName":"","lastName":"Sandi","suffix":""},{"id":469934105,"identity":"53fb53ee-2aa8-4d00-8cab-fb5716b645d3","order_by":23,"name":"Sıla Gerlevik","email":"","orcid":"","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Sıla","middleName":"","lastName":"Gerlevik","suffix":""},{"id":469934106,"identity":"d66b772e-05d0-40cd-9d35-c7b1a019f8ca","order_by":24,"name":"Paul Ntemi","email":"","orcid":"","institution":"Bugando Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Paul","middleName":"","lastName":"Ntemi","suffix":""},{"id":469934107,"identity":"3c94b9a3-2118-4de5-8a06-8672567667b8","order_by":25,"name":"Erick Magorosa","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Erick","middleName":"","lastName":"Magorosa","suffix":""},{"id":469934108,"identity":"659af65d-c6ec-42dd-a25b-5205859255cd","order_by":26,"name":"Daniel Mbwambo","email":"","orcid":"","institution":"Kilimanjaro Christian Medical Centre","correspondingAuthor":false,"prefix":"","firstName":"Daniel","middleName":"","lastName":"Mbwambo","suffix":""},{"id":469934109,"identity":"a350d39a-add9-4d39-ab40-3e1c658b43f2","order_by":27,"name":"Martin Ogwang","email":"","orcid":"","institution":"St. Mary's Hospital, Lacor","correspondingAuthor":false,"prefix":"","firstName":"Martin","middleName":"","lastName":"Ogwang","suffix":""},{"id":469934110,"identity":"2f916c42-cfcf-4349-90e4-5665f1b0d727","order_by":28,"name":"Faraja Chiwanga","email":"","orcid":"","institution":"Muhimbili National Hospital","correspondingAuthor":false,"prefix":"","firstName":"Faraja","middleName":"","lastName":"Chiwanga","suffix":""},{"id":469934111,"identity":"de0e8013-f2b8-4214-970d-690fadcda726","order_by":29,"name":"Claire El Mouden","email":"","orcid":"","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Claire","middleName":"El","lastName":"Mouden","suffix":""},{"id":469934112,"identity":"505b4504-c38e-4ba6-852b-e1a468d89a89","order_by":30,"name":"Emmanuel Balandya","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Emmanuel","middleName":"","lastName":"Balandya","suffix":""},{"id":469934113,"identity":"cf2e9598-8c14-45a6-8924-4c8923bcf5e4","order_by":31,"name":"Anthony Cutts","email":"","orcid":"","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Anthony","middleName":"","lastName":"Cutts","suffix":""},{"id":469934114,"identity":"cf9a0b60-28a1-4b64-82ce-1de58abb8331","order_by":32,"name":"Liz Morrell","email":"","orcid":"https://orcid.org/0000-0001-6382-1795","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Liz","middleName":"","lastName":"Morrell","suffix":""},{"id":469934115,"identity":"ad47b593-e1d7-4861-896d-d95ee063a953","order_by":33,"name":"Malale Tungu","email":"","orcid":"","institution":"Muhimbili University of Health and Allied Sciences","correspondingAuthor":false,"prefix":"","firstName":"Malale","middleName":"","lastName":"Tungu","suffix":""},{"id":469934116,"identity":"390fec94-749d-4e41-95e9-4ce4e1cc69aa","order_by":34,"name":"Sam Mbulaiteye","email":"","orcid":"https://orcid.org/0000-0002-8273-9831","institution":"National Cancer Institute, National Institutes of Health","correspondingAuthor":false,"prefix":"","firstName":"Sam","middleName":"","lastName":"Mbulaiteye","suffix":""},{"id":469934117,"identity":"f28234c0-9910-4b3c-9f95-82c744c1a7cd","order_by":35,"name":"Dimitrios Vavoulis","email":"","orcid":"https://orcid.org/0000-0002-3984-1507","institution":"University of Oxford","correspondingAuthor":false,"prefix":"","firstName":"Dimitrios","middleName":"","lastName":"Vavoulis","suffix":""},{"id":469934118,"identity":"04633c0c-4ae7-4608-aea8-8f2c70faa206","order_by":36,"name":"Anna Schuh","email":"","orcid":"https://orcid.org/0000-0002-3938-8490","institution":"Oxford University","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Schuh","suffix":""}],"badges":[],"createdAt":"2025-06-04 13:00:45","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6820773/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6820773/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41591-026-04291-z","type":"published","date":"2026-03-19T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":105040350,"identity":"2e1a3c86-b059-48b1-9f1d-de8f5c80be74","added_by":"auto","created_at":"2026-03-20 07:49:31","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1178804,"visible":true,"origin":"","legend":"","description":"","filename":"ClinicalvalidationandTATpapersubmittedNatureMedicine.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6820773/v1_covered_dedc9eb1-c309-4fab-a777-9d50f0c4e191.pdf"},{"id":86709688,"identity":"9544e616-608c-4c5c-99de-3a9a30caea5f","added_by":"auto","created_at":"2025-07-14 18:11:10","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":425741,"visible":true,"origin":"","legend":"Supplementary Data","description":"","filename":"SupplementaryData.docx","url":"https://assets-eu.researchsquare.com/files/rs-6820773/v1/3e8ab50cb9b2f9f90a0506c6.docx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"\u003cp\u003eClinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-6820773/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6820773/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBurkitt Lymphoma (BL) is common in sub-Saharan Africa, but its diagnosis is often delayed. Here, we comprehensively evaluate blood-based liquid biopsies from 377 children and young adults with clinically suspected lymphoma for diagnostic accuracy, yield and turnaround time (TAT). Following extensive pathology capacity building at participating study pathology sites to streamline and quality-ensure the histopathology assessment, diagnoses were reached from best local pathology consisting of tissue morphology, a previously validated limited immunohistochemistry (IHC) panel and review by at least two histopathologists, together called the \u0026ldquo;gold standard\u0026rdquo;. Next, we used a combination of clinical characteristics and circulating tumour DNA attributes (\u003cem\u003eMYC\u003c/em\u003e mutations, \u003cem\u003eMYC-IG\u003c/em\u003e translocations, and EBV fragmentomics) to train five different diagnostic models based on penalised logistic regression and 10-fold cross-validation on 212 children and young adults with clinically suspected lymphoma. External real-world validation was conducted on the best-performing model on a prospective cohort of 56 children and young adults with clinically suspected lymphoma. Diagnostic accuracy, yield and TAT for the liquid biopsy test were compared head-to-head against the gold-standard in 58 children and young adults with clinically suspected lymphoma. All five models showed good discrimination for BL (AUC\u0026thinsp;\u0026ge;\u0026thinsp;0.8). The comprehensive model had the best overall performance with AUC of 0.94 (95% CI: 0.895\u0026ndash;0.974; p\u0026thinsp;=\u0026thinsp;4.86\u0026times;10⁻⁴), sensitivity of 0.83, and specificity of 0.95 confirmed by external validation (AUC of 0.98 (95% CI: 0.942\u0026ndash;1)). Liquid biopsy was the only diagnostic result available in the multi-disciplinary team meeting in 42% (26/61) of participants and reduced the median diagnostic TAT from 46.8 days to 6.5 days (p\u0026thinsp;=\u0026thinsp;4.42e-10) compared to gold standard. This study demonstrates that our liquid biopsy model enables fast, highly accurate molecular diagnosis of EBV-positive BL. Its future integration into the diagnostic pathway may increase diagnostic accuracy and minimise treatment delays in resource-limited settings.\u003c/p\u003e","manuscriptTitle":"Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-07-14 18:11:05","doi":"10.21203/rs.3.rs-6820773/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-medicine","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"nm","sideBox":"Learn more about [Nature Medicine](http://www.nature.com/nm/)","snPcode":"","submissionUrl":"","title":"Nature Medicine","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Research","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"04c20dc5-070d-4058-8ea4-5403c7986332","owner":[],"postedDate":"July 14th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":51522041,"name":"Health sciences/Diseases/Haematological diseases/Haematological cancer/Lymphoma/Non-hodgkin lymphoma/B-cell lymphoma"},{"id":51522042,"name":"Health sciences/Diseases/Cancer/Cancer genomics"}],"tags":[],"updatedAt":"2026-03-20T07:46:11+00:00","versionOfRecord":{"articleIdentity":"rs-6820773","link":"https://doi.org/10.1038/s41591-026-04291-z","journal":{"identity":"nature-medicine","isVorOnly":false,"title":"Nature Medicine"},"publishedOn":"2026-03-19 04:00:00","publishedOnDateReadable":"March 19th, 2026"},"versionCreatedAt":"2025-07-14 18:11:05","video":"","vorDoi":"10.1038/s41591-026-04291-z","vorDoiUrl":"https://doi.org/10.1038/s41591-026-04291-z","workflowStages":[]},"version":"v1","identity":"rs-6820773","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6820773","identity":"rs-6820773","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0